These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13656334)

  • 1. [Comparative studies on the side-effects of estrogen therapy in the use of various types of hormones in patients with prostate carcinoma & adenoma].
    TAUPITZ A
    Medizinische; 1959 May; 4(18):873-6. PubMed ID: 13656334
    [No Abstract]   [Full Text] [Related]  

  • 2. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS; Pitts WR
    J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen therapy in carcinoma of the prostate.
    BIRKE G; FRANKSSON C; PLANTIN LO
    Acta Chir Scand; 1955 Apr; 109(1):1-10. PubMed ID: 14387447
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of transdermal estradiol in androgen-independent prostate carcinoma.
    Bland LB; Garzotto M; DeLoughery TG; Ryan CW; Schuff KG; Wersinger EM; Lemmon D; Beer TM
    Cancer; 2005 Feb; 103(4):717-23. PubMed ID: 15641029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary endocrine therapy with oral estrogen for relapsed prostate cancer].
    Onita T; Igawa T; Hisamatsu H; Sakai H; Kanetake H
    Hinyokika Kiyo; 2009 Oct; 55(10):595-8. PubMed ID: 19926941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary report on oral honvan therapy of prostate carcinoma].
    WARNECKE CE
    Medizinische; 1957 Nov; 25(44):1625-7. PubMed ID: 13492945
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of stilbo-estrol phosphate in prostate carcinoma].
    HOHLWEG W; GROOT-WASSINK KA
    Dtsch Gesundheitsw; 1959 Jan; 14(4):152-7. PubMed ID: 13639631
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammary neoplasm in a male receiving oestrogen therapy for carcinoma of the prostate.
    MOULTON JE
    Med J Aust; 1959 May; 1(21):706-7. PubMed ID: 13666165
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
    Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
    J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progynon, a depot preparation with oestrogenic action, in the treatment of prostatic carcinoma.
    Birke G; Wadström LB
    Acta Chir Scand; 1965 Oct; 130(4):388-92. PubMed ID: 5842513
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis in patients with metastatic carcinoma of the prostate gland.
    DOLAZ EJ; DOLEHIDE RA; FRIEDMAN IA
    Ill Med J; 1955 Mar; 107(3):142-4. PubMed ID: 14353517
    [No Abstract]   [Full Text] [Related]  

  • 12. [Secondary cancer of the lung of prostatic origin; recovery maintained for 3 years by diethylstilbestrol therapy].
    MEYER A; LIOT F
    Bull Mem Soc Med Hop Paris; 1954 Mar 26-Apr 9; 70(11-12):401-4. PubMed ID: 13172629
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estrogen depot injections in therapy of carcinoma of the prostate].
    FRANCESE A
    Gazz Med Ital; 1953 May; 112(5):138-41. PubMed ID: 13083870
    [No Abstract]   [Full Text] [Related]  

  • 14. Planned cytostatic therapy of carcinoma of the prostate.
    WARNECKE CE
    Bruns Beitr Klin Chir; 1955 May; 190(3):341-8. PubMed ID: 14389781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of conservative therapy in prostate carcinoma].
    PAGEL W
    Z Urol; 1957; 50(12):681-8. PubMed ID: 13531567
    [No Abstract]   [Full Text] [Related]  

  • 16. Diethylstitboestrol in the treatment of inoperable carcinoma of the prostate: a preliminary report.
    MACKINNON KJ; NEARING TN; CARRUTHERS NC
    Can Med Assoc J; 1957 Dec; 77(11):1009-12. PubMed ID: 13489589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Organ-specific chemotherapy of carcinoma of the prostate].
    BUDNIOK R; STOLL HG; ALTVATER G
    Dtsch Med Wochenschr; 1955 Jan; 80(4):143-6. PubMed ID: 14352775
    [No Abstract]   [Full Text] [Related]  

  • 18. Endocrine inhibition as related to carcinoma of the prostate.
    VALK WL; OWENS RH
    Trans South Cent Sect Am Urol Assoc; 1953; 48():55-65. PubMed ID: 13187581
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of 200 cases of carcinoma of the prostate treated conservatively.
    SATTER EJ; WEAR JB
    Wis Med J; 1958 Sep; 57(9):327-9. PubMed ID: 13581738
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conservative treatment of carcinoma of the prostate with organ-specific chemotherapy].
    SCHAFER W
    Dtsch Med Wochenschr; 1954 Feb; 79(6):221-3. PubMed ID: 13150842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.